Narrowband UV-B Produces Superior Clinical and Histopathological Resolution of Moderate-to-Severe Psoriasis in Patients Compared With Broadband UV-B2

Archives of Dermatology

Volumn 133, Issue 12, 1997, Pages 1514-1522

  Coven, Todd R ^a   Burack, Lauren H ^a   Gilleaudeau, Patricia ^a   Keogh, Mary ^b   Ozawa, Maki ^a   Krueger, James G ^a  

^a Forest Laboratories   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACANTHOSIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; KERATINOCYTE; MALE; OUTCOMES RESEARCH; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; RADIATION EXPOSURE; SCORING SYSTEM; ULTRAVIOLET B RADIATION;

ADOLESCENT; ADULT; AGED; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; PUVA THERAPY; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 15144359977     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1997.03890480034005     Document Type: Article

References (39)

1. Greaves MW, Weinstein GD. Treatment of psoriasis. N Engl J Med. 1995;332: 581-588.
2. Liem WH, McCullough JL, Weinstein GD. Effectiveness of topical therapy for psoriasis: results of a national survey. Cutis. 1995;55:306-310.
3. Goeckerman WH. The treatment of psoriasis. Northwest Med. 1925;24:229-231.
4. Larko O. Phototherapy of psoriasis: clinical aspects and risk evaluation. Acta Derm Venereol. 1982;103(suppl):1-42.
5. Belsito DV, Kechijian P. The role of tar in Goeckerman therapy. Arch Dermatol. 1982;118:319-321.
6. Adrian RM, Parrish JA, Khosrow MT, Karlin MJ. Outpatient phototherapy for psoriasis. Arch Dermatol. 1981;117:623-626.
7. Le Vine MJ, Parrish JA. Outpatient phototherapy of psoriasis. Arch Dermatol. 1980;116:552-554.
8. Boer J, Schothorst AA, Suurmond D. UV-B phototherapy of psoriasis. Dermatologica. 1980;161:250-258.
9. Le Vine MJ, White HAD, Parrish JA. Components of the Goeckerman regimen. J Invest Dermatol. 1979;73:170-173.
10. Petrozzi JW, Barton JO, Kaidbey KK, Kligman AM. Updating the Goeckerman regimen for psoriasis. Br J Dermatol. 1978;98:437-444.
11. Koo J. The art of UV-B phototherapy for the treatment of psoriasis. In: Weinstein GD, Gottlieb AB, eds. Therapy of Moderate-to-Severe Psoriasis. Stamford, Conn: Haber & Flora Inc; 1993:56-74.
12. Stern RS, Armstrong RB, Anderson TF, et al. Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study. J Am Acad Dermatol. 1986;15:546-552.
13. Anderson TF, Waldinger TP, Voorhees JJ. UV-B phototherapy: an overview. Arch Dermatol. 1984;120:1502-1507.
14. Melski JW, Tannenbaum L, Parrish JS, Fitzpatrick TB, Bleich HL. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol. 1977;68:328-335.
15. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med. 1997;336:1041-1045.
16. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Cancer. 1994;73:2759-2764.
17. Fischer T. UV-light treatment of psoriasis. Acta Derm Venereol (Stockh). 1976; 56:473-479.
18. Parrish JA, Jaenicke KF. Action spectrum of phototherapy of psoriasis. J Invest Dermatol. 1981;76:359-362.
19. Storbeck K, Holzle E, Schurer N, Lehmann P, Plewig G. Narrow-band UV-B (311 nm) versus conventional broad-band UV-B with and without dithranol in phototherapy for psoriasis. J Am Acad Dermatol. 1993;28:227-231.
20. Green C, Lakshmipathi T, Johnson BE, Ferguson J. A comparison of the efficacy and relapse rates of narrowband UV-B (TL-01) monotherapy vs etretinate (re-TL-01) vs etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients. Br J Dermatol. 1992;127:5-9.
21. Picot E, Meunier L, Picot-Debeze MC, Peyron JL, Meynadier J. Treatment of psoriasis with a 311-nm UV-B lamp. Br J Dermatol. 1992;127:509-512.
22. Van Weelden H, Baart de la Faille H, Young E, van der Leun JC. A new development in UV-B phototherapy of psoriasis. Br J Dermatol. 1988;119:11-19.
23. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UV-B phototherapy—an effective treatment for psoriasis. Br J Dermatol. 1988;119:691-696.
24. Van Weelden H, Baart de la Faille H, Young E, van der Leun JC. Comparison of narrow-band UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol (Stockh). 1990;70:212-215.
25. Everett MA, Yeargers E, Sayre RM, Olson RL. Penetration of epidermis by ultraviolet rays. Photochem Photobiol. 1966;5:533-542.
26. Anderson RR, Parrish JA. The optics of human skin. J Invest Dermatol. 1981; 77:13-19.
27. Gilchrest BA, Soter NA, Stoff JS, Mihm MC Jr. The human sunburn reaction: histologic and biochemical studies. J Am Acad Dermatol. 1981;5:411-422.
28. Rosario R, Mark GJ, Parrish JA, Mihm MC Jr. Histological changes produced in skin by equally erythemogenic doses of UV-A, UV-B, UV-C and UV-A with psoralens. Br J Dermatol. 1979;101:299-308.
29. Vallat VP, Gilleaudeau P, Battat L, et al. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med. 1994;180:283-296.
30. Gottlieb SL, Gilleaudeau P, Johnson R, et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med. 1995;1:442-447.
31. Diffey BL, Farr PM. An appraisal of ultraviolet lamps used for the phototherapy of psoriasis. Br J Dermatol. 1987;117:49-56.
32. Krueger JG, Wolfe JT, Nabeya RT, et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med. 1995;182:2057-2068.
33. Szabo SK, Hammerberg C, Bata-Csorgo ZS, Cooper KD, Szent-Gyorgyi A. The mechanism of action of UV-B in psoriasis: rapidly decreased T cell numbers and preferential reduction of interferon (IFN) production. J Invest Dermatol. 1997; 108:558.
34. George SA, Ferguson J. Lesional blistering following narrow-band (TL-01) UV-B phototherapy for psoriasis: a report of four cases. Br J Dermatol. 1992;127:445-446.
35. Young AR. Photocarcinogenicity of psoralens used in PUVA treatment: present status in mouse and man. J Photochem Photobiol. 1990;6:237-247.
36. Enninga IC, Groenendijk RTL, Filon AR, van Zeeland AA, Simons JWIM. The wave-length dependence of U.V.-induced pyrimidine dimer formation, cell killing and mutation induction in human diploid skin fibroblasts. Carcinogenesis. 1986;7:1829-1836.
37. Freeman RG. Data on the action spectrum for ultraviolet carcinogenesis. J Natl Cancer Inst. 1975;55:1119-1122.
38. Flindt-Hansen H, McFadden N, Eeg-Larsen T, Thune P. Effect of a new narrow-band UV-B lamp on photocarcinogenesis in mice. Acta Derm Venereol (Stockh). 1991;71:245-248.
39. Wulf HC, Hansen AB, Bech-Thomsen N. Differences in narrow-band ultraviolet B and broad-spectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. Photodermatol Photoimmunol Photomed. 1994;10:192-197.